Atragen approval denied

Published: 3-Feb-2001


The US FDA has denied approval of Aronex's Atragen (tretinoin liposime for injection) for the treatment of acute promyelotic leukaemia. The FDA says it turned down the application as it could not see an identifiable population that could not take the oral form.

You may also like